Can sleep-disordered breathing repeatedly fragment sleep and lower oxygen during the night, especially in older adults with Alzheimer’s disease?

Sleep-disordered breathing—particularly obstructive sleep apnea (OSA)—is clinically important to consider in a 78-year-old woman with Alzheimer’s disease because it can produce objectively measurable sleep disruption and recurrent nocturnal hypoxemia, and its presentation may be less typical in later life.

Physiologic and clinical evidence

• Recurrent apneas, hypopneas, and respiratory-effort–related events commonly end in brief EEG-defined arousals. These repeated arousals fragment sleep, including when respiratory-effort–related events do not produce a measurable desaturation.
• Obstructive events can also cause cyclic desaturation–reoxygenation, i.e., intermittent nocturnal hypoxemia. Sleep fragmentation and oxygen burden are related but distinct: the arousal index and oxygen-desaturation index measure different dimensions of illness severity.
• Polysomnography can directly link airflow limitation and respiratory effort to EEG arousals and oxygen-saturation changes. Symptom questionnaires alone are not sufficient for confirmation.

Age, cognition, and Alzheimer’s disease

• Moderate-to-severe OSA is common in older adults, but excessive daytime sleepiness may be absent, muted, or difficult to distinguish from multimorbidity and cognitive illness.
• In adults older than 65 years without dementia, lower mean overnight oxygen saturation and more time spent below 90% saturation were associated with steeper decline on selected cognitive tests over five years; these observational findings do not prove causation.
• Alzheimer’s disease is associated with approximately fivefold higher odds of OSA versus age-comparable controls. This association does not establish that OSA causes Alzheimer’s disease.

Diagnostic and treatment implications

• Attended polysomnography is the diagnostic standard. Home sleep-apnea testing may be appropriate for selected uncomplicated adults, but unreliable acquisition in cognitive impairment favors attended testing; a negative or inconclusive home test should be followed by polysomnography.
• Small Alzheimer’s trials suggest CPAP may improve sleep quality and daytime sleepiness, with possible short-term cognitive benefit, but durable cognitive or disease-modifying effects remain unproven.

Bottom line

• Sleep-disordered breathing can plausibly and repeatedly disrupt sleep and lower oxygen during the night; advanced age and Alzheimer’s disease make objective assessment particularly relevant, chiefly to identify a potentially treatable contributor to impaired sleep and nocturnal hypoxemia.